Cargando…
Allogeneic hematopoietic stem cell transplantation should be in preference to conventional chemotherapy as post-remission treatment for adults with lymphoblastic lymphoma
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173686/ https://www.ncbi.nlm.nih.gov/pubmed/29712994 http://dx.doi.org/10.1038/s41409-018-0184-7 |
| _version_ | 1783361159345209344 |
|---|---|
| author | Yang, Luxin Tan, Yamin Shi, Jimin Zhao, Yanmin Zhu, Yuanyuan Hu, Yongxian Pan, Wenjue Ye, Yishan He, Jingsong Zheng, Weiyan Sun, Jie Cai, Zhen Huang, He Luo, Yi |
| author_facet | Yang, Luxin Tan, Yamin Shi, Jimin Zhao, Yanmin Zhu, Yuanyuan Hu, Yongxian Pan, Wenjue Ye, Yishan He, Jingsong Zheng, Weiyan Sun, Jie Cai, Zhen Huang, He Luo, Yi |
| author_sort | Yang, Luxin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6173686 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-61736862018-10-11 Allogeneic hematopoietic stem cell transplantation should be in preference to conventional chemotherapy as post-remission treatment for adults with lymphoblastic lymphoma Yang, Luxin Tan, Yamin Shi, Jimin Zhao, Yanmin Zhu, Yuanyuan Hu, Yongxian Pan, Wenjue Ye, Yishan He, Jingsong Zheng, Weiyan Sun, Jie Cai, Zhen Huang, He Luo, Yi Bone Marrow Transplant Correspondence Nature Publishing Group UK 2018-04-30 2018 /pmc/articles/PMC6173686/ /pubmed/29712994 http://dx.doi.org/10.1038/s41409-018-0184-7 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Correspondence Yang, Luxin Tan, Yamin Shi, Jimin Zhao, Yanmin Zhu, Yuanyuan Hu, Yongxian Pan, Wenjue Ye, Yishan He, Jingsong Zheng, Weiyan Sun, Jie Cai, Zhen Huang, He Luo, Yi Allogeneic hematopoietic stem cell transplantation should be in preference to conventional chemotherapy as post-remission treatment for adults with lymphoblastic lymphoma |
| title | Allogeneic hematopoietic stem cell transplantation should be in preference to conventional chemotherapy as post-remission treatment for adults with lymphoblastic lymphoma |
| title_full | Allogeneic hematopoietic stem cell transplantation should be in preference to conventional chemotherapy as post-remission treatment for adults with lymphoblastic lymphoma |
| title_fullStr | Allogeneic hematopoietic stem cell transplantation should be in preference to conventional chemotherapy as post-remission treatment for adults with lymphoblastic lymphoma |
| title_full_unstemmed | Allogeneic hematopoietic stem cell transplantation should be in preference to conventional chemotherapy as post-remission treatment for adults with lymphoblastic lymphoma |
| title_short | Allogeneic hematopoietic stem cell transplantation should be in preference to conventional chemotherapy as post-remission treatment for adults with lymphoblastic lymphoma |
| title_sort | allogeneic hematopoietic stem cell transplantation should be in preference to conventional chemotherapy as post-remission treatment for adults with lymphoblastic lymphoma |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173686/ https://www.ncbi.nlm.nih.gov/pubmed/29712994 http://dx.doi.org/10.1038/s41409-018-0184-7 |
| work_keys_str_mv | AT yangluxin allogeneichematopoieticstemcelltransplantationshouldbeinpreferencetoconventionalchemotherapyaspostremissiontreatmentforadultswithlymphoblasticlymphoma AT tanyamin allogeneichematopoieticstemcelltransplantationshouldbeinpreferencetoconventionalchemotherapyaspostremissiontreatmentforadultswithlymphoblasticlymphoma AT shijimin allogeneichematopoieticstemcelltransplantationshouldbeinpreferencetoconventionalchemotherapyaspostremissiontreatmentforadultswithlymphoblasticlymphoma AT zhaoyanmin allogeneichematopoieticstemcelltransplantationshouldbeinpreferencetoconventionalchemotherapyaspostremissiontreatmentforadultswithlymphoblasticlymphoma AT zhuyuanyuan allogeneichematopoieticstemcelltransplantationshouldbeinpreferencetoconventionalchemotherapyaspostremissiontreatmentforadultswithlymphoblasticlymphoma AT huyongxian allogeneichematopoieticstemcelltransplantationshouldbeinpreferencetoconventionalchemotherapyaspostremissiontreatmentforadultswithlymphoblasticlymphoma AT panwenjue allogeneichematopoieticstemcelltransplantationshouldbeinpreferencetoconventionalchemotherapyaspostremissiontreatmentforadultswithlymphoblasticlymphoma AT yeyishan allogeneichematopoieticstemcelltransplantationshouldbeinpreferencetoconventionalchemotherapyaspostremissiontreatmentforadultswithlymphoblasticlymphoma AT hejingsong allogeneichematopoieticstemcelltransplantationshouldbeinpreferencetoconventionalchemotherapyaspostremissiontreatmentforadultswithlymphoblasticlymphoma AT zhengweiyan allogeneichematopoieticstemcelltransplantationshouldbeinpreferencetoconventionalchemotherapyaspostremissiontreatmentforadultswithlymphoblasticlymphoma AT sunjie allogeneichematopoieticstemcelltransplantationshouldbeinpreferencetoconventionalchemotherapyaspostremissiontreatmentforadultswithlymphoblasticlymphoma AT caizhen allogeneichematopoieticstemcelltransplantationshouldbeinpreferencetoconventionalchemotherapyaspostremissiontreatmentforadultswithlymphoblasticlymphoma AT huanghe allogeneichematopoieticstemcelltransplantationshouldbeinpreferencetoconventionalchemotherapyaspostremissiontreatmentforadultswithlymphoblasticlymphoma AT luoyi allogeneichematopoieticstemcelltransplantationshouldbeinpreferencetoconventionalchemotherapyaspostremissiontreatmentforadultswithlymphoblasticlymphoma |